Categories: All postsAnalysts

Mackie Research lowers target on theScore, maintains buy rating

theScore Chairman and CEO John Levy.

Following a lackluster quarter, Mackie Research Capital analyst Nikhil Thadani today lowered his price target on theScore (theScore Stock Quote, Chart, News: TSXV:SCR) from $.50 to $.45, although he maintained his “Buy” recommendation on the stock. His new target implied a return of 150 per cent at the time of publication.

This morning, theScore reported its Q2, 2017 results. The company lost $2.1-million on revenue of $6.7-million, a topline that was up 15.5 per cent over the $5.8-million in revenue the company reported in the same period last year.

“This quarter saw us once again strengthen the engagement within our mobile apps while increasing the sophistication of our advertising business to drive ongoing revenue growth and positively impact our pathway to profitability,” said CEO John Levy. “Our product team remains focused on the continued enhancement of our flagship sports app, with new features being rolled out over the remainder of fiscal 2017, while also supporting other areas of our business, like esports and bots, to ensure we’re meeting the evolving needs of sports fans.”

Thadani says theScore is a company in need of catalysts, though he believes there is plenty of value in the stock.

“Our 45¢/sh reflects ~3.5x forward sales, roughly in-line with advertising driven peers,” he says. “Investors have been wanting to see user base growth for some time, Q2 (Feb) core app Monthly Active Users (MAUs) of 4.3 mln vs. our 4.5 mln estimate is unlikely to convince investors.”

Thadani thinks theScore will post EBITDA of negative $5.8-million on revenue of $26.6-million in fiscal 2017. He expects those numbers will improve to positive EBITDA of $1.0-million on a topline of $35.7-million the following year.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: scr
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

4 hours ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

11 hours ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

12 hours ago

Is Wolfspeed stock still a buy?

Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]

12 hours ago

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

1 day ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

1 day ago